Form 4: Myriad Genetics SVP Margaret Ancona Reports Stock Disposal for Tax Obligations
SEC Form 4
Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, disposed of 966 shares of common stock on September 21, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 21, 2024, Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, disposed of 966 shares of Myriad Genetics Inc. common stock.
- The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units.
- The shares were disposed of at a price of $27.64 per share.
- Following the transaction, Ancona directly owns 78,400 shares of Myriad Genetics Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no significant positive or negative implications for the company's performance.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is related to tax obligations from vested stock, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Date used to determine the closing price of Myriad common stock for tax withholding. |
| 09/21/2024 | Date of the stock disposal transaction. |
| 09/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.